Dorlimomab aritox

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameDorlimomab aritox
Drug Alias NameMonoclonal antibody ricin AMDX-RA4197X-RA
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibodyBiologics > Protein drugs > Toxin
Mechanisms of ActionImmunomodulators
TargetsNot applicable
Therapy Area/IndicationsCataract
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Phase 3 Clinical)
Highest Status in ChinaN/A
Originator CompaniesMedarex Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesMedarex IncSanten
Active IndicationsN/A
Inactive IndicationsCataract

Other Information

ATC CodeN/A
Related LinksN/A